COSMOS HEALTH, INC.
BGSF: Click to Subscribe to Email Notifications
View Company Website: Click to View
Market Data: Yahoo Finance, Bloomberg, SEC Filings
Report Link: Final Report Released (Dated March 3, 2025)
Symbol: COSM
Analyst: Howard Halpern
Taglich Rating: N/A
Price Target: N/A
Time Horizon: N/A
Rating Established: March 3, 2025
Price When Established: $0.54
Most Recent Report: March 3, 2025
Price When Issued: $0.50
What’s New
New information will be posted soon…
Company Description
Cosmos Health Inc., headquartered in Chicago, Illinois is a diversified vertically integrated global health organization that manufactures and distributes medical grade nutritional and medicines. Cosmos owns a portfolio of proprietary pharmaceutical and nutraceutical brands (Sky Premium Life®, Mediterranation®, bio-bebe® and C-Sept®). Its CANA Pharmaceuticals Laboratories subsidiary is licensed to manufacture pharmaceuticals, food supplements, cosmetics, biocides, and medical devices within the European Union. COSM also distributes a broad line of pharmaceuticals and parapharmaceuticals that includes branded, generics, and OTC medications to retail pharmacies and wholesale distributors in Greece and the United Kingdom. Through a repurposing drug program, COSM is targeting major health disorders such as obesity, diabetes, and cancer.